![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 27, 25478-25484, July 8, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


From the Department of Medical Biochemistry and Microbiology, Uppsala University, 75123 Uppsala, Sweden
U2AF has been characterized as an essential splicing factor required for efficient recruitment of U2 small nuclear ribonucleoprotein to the 3'-splice site in a pre-mRNA. The U2AF65 subunit binds to the pyrimidine tract of the pre-mRNA, whereas the U2AF35 subunit contacts the 3'-splice site AG. Here we show that U2AF35 appears to be completely dispensable for splicing in nuclear extracts prepared from adenovirus late-infected cells (Ad-NE). As a consequence, the viral IIIa and cellular IgM introns, which both have suboptimal 3'-splice sites and require U2AF35 for splicing in nuclear extracts from uninfected cells, are transformed to U2AF35-independent introns in Ad-NE. Furthermore, we present evidence that two parallel pathways of 3'-splice site recognition exist in Ad-NE. We show that the viral 52,55K intron, which has an extended pyrimidine tract, requires U2AF for activity in Ad-NE. In contrast, the IgM intron, which has a weak 3'-splice site sequence context, undergoes the first catalytic step of splicing in U2AF-depleted Ad-NE, suggesting that spliceosome assembly occurs through a novel U2AF-independent pathway in Ad-NE.
Received for publication, December 7, 2004 , and in revised form, April 25, 2005.
* This work was supported by the Swedish Cancer Society and the Wallenberg Consortium North. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at
http://www.jbc.org)
contains Supplementary Figs. 1 and 2.
Present address: Dept. of Molecular Biology, University of Aarhus, C.F.
Møllers Alle, Bldg. 130, DK-8000 Aarhus C, Denmark.
To whom correspondence should be addressed: Dept. of Medical Biochemistry and
Microbiology, The Biomedical Center, Uppsala University, Husargatan 3, Box
582, 75123 Uppsala, Sweden. Tel.: 46-18-4714164; Fax: 46-18-509876: E-mail:
goran.akusjarvi{at}imbim.uu.se.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. T. Little and M. S. Jurica Splicing Factor SPF30 Bridges an Interaction between the Prespliceosome Protein U2AF35 and Tri-small Nuclear Ribonucleoprotein Protein hPrp3 J. Biol. Chem., March 28, 2008; 283(13): 8145 - 8152. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sridharan and R. Singh A Conditional Role of U2AF in Splicing of Introns with Unconventional Polypyrimidine Tracts Mol. Cell. Biol., October 15, 2007; 27(20): 7334 - 7344. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tormanen, E. Backstrom, A. Carlsson, and G. Akusjarvi L4-33K, an Adenovirus-encoded Alternative RNA Splicing Factor J. Biol. Chem., December 1, 2006; 281(48): 36510 - 36517. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |